Caitong International Asset Management’s Veraxa Biotech AG VRXA Stock Holding History

Caitong International Asset Management’s Portfolio VRXA Stock Details VRXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11	Buy	+6	New	+$48	﹤0.01%	2636

Other funds holding VRXA

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 51.47% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Caitong International Asset Management's VRXA Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in Veraxa Biotech AG (VRXA) in Q2 2026: 6 shares worth $11. The stake represents ﹤0.01% of the portfolio and ranks #2636 among its holdings.

6 funds tracked by Wall St. Rank hold VRXA as of Q2 2026.

Caitong International Asset Management held 6 shares of Veraxa Biotech AG worth $11 as of Q2 2026.
Veraxa Biotech AG was a new Caitong International Asset Management position in Q2 2026.
Veraxa Biotech AG made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2636 holding.
6 funds tracked by Wall St. Rank held Veraxa Biotech AG as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.